S udden cardiac death (SCD) remains a major and unresolved public health problem, claiming 300 000 lives a year in the United States alone. Previous myocardial infarction (MI) can be identified in 75% of SCD victims. 1 In most cases, the direct cause of SCD is ventricular fibrillation (VF), which is usually preceded by ventricular tachycardia (VT). The interaction between VT (the "trigger") and the diseased myocardium (the "substrate") results in the transition of VT to VF 2 and subsequent SCD. There are a number of experimental models [3] [4] [5] [6] [7] [8] [9] in which ventricular tachyarrhythmias have been provoked in the presence or absence of structural alterations imposed on the myocardium. However, the investigators induced ischemia or provided artificial triggers, such as electrical stimulation or drugs, to induce VT or VF. The only SCD model in which VT occurs spontaneously 10 was in dogs with inherited ventricular arrhythmia. This latter model may not be applicable to the vast majority of patients whose vulnerability to SCD develops after they have suffered an MI. To date, no high-yield animal model exists in which SCD caused by VF occurs spontaneously in chronic MI. Recently, Vos et al 11 reported that complete atrioventricular (AV) block may result in electrical remodeling and enhance the susceptibility to acquired torsade de pointes. It is also known that sympathetic activity is important in the generation of spontaneous ventricular ectopy and SCD after MI 12, 13 and that stimulating the left stellate ganglion enhances cardiac arrhythmogenesis. 4,6,14 -17 On the basis of these findings, we hypothesize that induction of increased sympathetic nerve sprouting by nerve growth factor (NGF) infusion to the left stellate ganglion in dogs with complete AV block 11, 18 and MI may increase the frequency of ventricular arrhythmia. A combination of this trigger and the diseased myocardium (the substrate) may result in a high-yield animal model of spontaneous SCD. The purpose of the present study was to test these hypotheses.
Materials and Methods

Induction of Cardiac Nerve Sprouting by NGF Infusion
We first developed a method to induce cardiac nerve sprouting and hyperinnervation. The method was tested in 3 dogs. NGF 7S was infused into the left stellate ganglion via an osmotic pump. One month later, the hearts were removed for immunocytochemical studies of myocardial innervation.
Animal Model of Spontaneous SCD After MI
The experimental (NGF) group underwent survival surgery in which AV block was created by catheter ablation. An implantable cardioverter-defibrillator (ICD, Guidant model 1762 or 1810) was implanted. The ICD was programmed to the monitor-only mode with a back-up pacing rate of 40 bpm. During follow-up, the ICD declared VT episodes once the ventricular rate exceeded 100 bpm for 8 of 10 beats. An osmotic pump was implanted to infuse NGF to the left stellate ganglion. The left anterior descending coronary artery (LAD) was ligated below the first diagonal branch to create MI. The dog was allowed to recover for up to 3 months. The control group underwent the same procedures to create AV block and MI. However, we did not infuse NGF in the control group.
Immunocytochemical Studies
Left ventricular tissues from the edge of the posterior papillary muscle, the anterior papillary muscle, and the interventricular septum of the middle sections were used for immunocytochemical studies. We also sectioned the tissues in the AV nodal region for immunocytochemical studies. The nerve markers tyrosine hydroxylase (TH), synaptophysin (SYN), and growth-associated protein 43 (GAP43) were stained.
Statistical Analysis
Student's t tests were used to compare the means between 2 groups. To quantify the periodic structure of the frequency of occurrence of VT, single and double harmonic regression models were fitted to the data. 19 The null hypothesis was rejected at a value of PՅ0.05.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results
NGF-Induced Nerve Sprouting and Hyperinnervation in Normal Dogs
In normal canine hearts without NGF infusion, the numbers of nerves per mm 2 that stained positive for TH and SYN were 14.9Ϯ2.0 and 22.9Ϯ1.7, respectively. The GAP43 stains were negative in these tissues, indicating the absence of nerve sprouting in normal dogs. In comparison, the densities (numbers of nerve fibers/mm 2 ) of nerves that stained positive for TH, SYN, and GAP43 ( Figure 1A through 1C) were 24.7Ϯ1.6, 37.7Ϯ2.3, and 18.4Ϯ7.3, respectively, in normal dogs that received NGF infusion to the left stellate ganglion (PϽ0.01 for all comparisons). These results indicate that NGF infusion to the left stellate ganglion induced significant cardiac nerve sprouting in normal dogs.
NGF-Induced Nerve Sprouting and Hyperinnervation in Dogs With MI and AV Block
There was significantly greater ventricular sympathetic nerve density (Table) in the experimental (NGF-treated) group (examples in Figure 1D through 1F) than in the control group (examples in Figure 1G through 1I). The presence of GAP43-positive nerves in the control group suggests that a certain degree of nerve sprouting occurs after MI even without NGF infusion.
In all dogs, abundant sympathetic nerves were observed in the region of the AV node. These nerves stained positive for TH, SYN, and GAP43 ( Figure 2 ). These findings indicate that radiofrequency ablation of the AV node did not destroy sympathetic fibers passing through that area.
Spontaneous VT, VF, and SCD After MI
A total of 15 dogs (9 in experimental group and 6 in control group) survived the first surgery. The ventricular escape rate after a successful AV junction ablation was between 38 and 65 bpm in all dogs studied. The dogs were followed for 43Ϯ25 days (experimental group) and 68Ϯ25 days (control group) before SCD or a second surgery for tissue harvesting. Four (44%) of the 9 dogs in the experimental group died suddenly of VF at days 11, 17, 60, and 25 ( Figure 3 ). In comparison, none in the control group died during follow-up. All dogs developed spontaneous VT after surgery. These episodes persisted for 5.8Ϯ2.0 days (phase 1 VT) before subsiding. Spontaneous VT reappeared 13.1Ϯ6.0 days after surgery (phase 2 VT) ( Figure 4 and Figure 1 online; see http://www.circresaha.org). On average, there was an arrhythmia-free period of 7.3Ϯ5.8 days (range, 2 to 20 days) between VT phases 1 and 2. The average number of phase 2 VT episodes within 60 days after first surgery was 10-fold greater in the experimental group (2.0Ϯ2.0 per day) than in the control group (0.2Ϯ0.2 per day, PϽ0.05).
The average heart and body weights in the experimental group (259Ϯ37 g and 25Ϯ3 kg) were not significantly different from those in the control group (226Ϯ25 g and 23Ϯ2 kg, Pϭ0.09 and Pϭ0.14, respectively). Among the dogs in the experimental group, the heart weight of dogs that died of SCD (249Ϯ48 g) was not statistically different from that of the dogs that did not die of SCD (269Ϯ25 g). There were no significant differences between the infarct size in the experimental group (17Ϯ4%) and the control group (14Ϯ4%).
Evidence for Increased Sympathetic Activity During the Initiation of VT and SCD
The phase 2 VTs may have been triggered by increased sympathetic activity. When the dogs were at rest, the ventricular rate was 60Ϯ10 bpm (61Ϯ10 bpm for the experimental group and 59Ϯ12 bpm for the control group, PϭNS). In comparison, immediately before the onset of VT, the ventricular rate was 75Ϯ14 bpm (PϽ0.01). In 10 animals, atrial activation rate could be determined by visual inspection of the electrogram stored by ICD. The atrial rate immediately before the VT averaged 192Ϯ24 bpm. After the VT spontaneously stopped, there was a transient but remarkable reduction of the atrial rate to 132Ϯ37 bpm (PϽ0.01) (Figure 5 ), suggesting vagal activation and/or sympathetic withdrawal before VT termination.
The phase 2 VT occurred throughout the day ( Figure 6 ), with the maximum frequency occurring in the morning. In the experimental group, the single harmonic fit to the data was statistically significant (PϽ0.05), indicating a periodic nature of VT. For this model, the estimated coefficient for the sine term was significantly different from zero (Pϭ0.0285), whereas the coefficient of the cosine term was statistically indistinguishable from zero. The R 2 for this model was 0.30. The single-harmonic equation for the frequency of VT was as follows: VT per hourϭ11.6Ϫ5.1 cos (2t/24)ϩ6.4 sin (2t/ 24), where t is the time of day in hours. The same analyses for the control group showed no statistically significant periodicity in the occurrence of phase 2 VT. SCD in 4 dogs of the experimental group occurred at 10:22 AM, 12:33 PM, 1:42 PM, and 5:30 AM. Two SCD episodes were witnessed by technicians in the room. These 2 dogs were not exercising or feeding at the time of death. The other 2 SCD episodes were not witnessed, and the dog's activities at the time of death were unknown.
Among 148 episodes of phase 2 VT or VF in which the stored electrograms were available, the patterns of onset were premature ventricular contraction on the T wave with longshort coupling interval (type 1) in 46 (31%), premature ventricular contraction without long-short coupling (type 2) in 51 (34.5%), and acceleration of ventricular escape rhythm into the VT zone (type 3) in 51 (34.5%). The mean rates (bpm) were 217Ϯ98, 141Ϯ28, and 119Ϯ22 for VT types 1, 2, and 3, respectively (PϽ0.01 for all comparisons). Figure 3 shows that 3 VF episodes had type I onset (dogs 2, 6, and 9), and 1 was preceded by type 2 onset (dog 4). *For all 3 stains, the nerve density of the experimental group was significantly higher than the nerve density of the control group. The P value was Ͻ0.02 for comparison of SYN between experimental and control groups. In all other comparisons, the P value was Ͻ0.01. 
Nerve Density
Discussion
In this study, we have developed a high-yield animal model of spontaneous VT, VF, and SCD after chronic MI. Because the only difference between the experimental group and the control group was the presence of increased nerve sprouting in the former, these results also suggest a direct relationship between sympathetic nerve sprouting and SCD in this model. 
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Mechanisms of SCD
The initiation of spontaneous VT, VF, and SCD depends on the presence of both substrate(s) and trigger(s). The anatomic and functional 20 heterogeneities induced by MI or AV block may serve as the substrates for SCD. However, the presence of MI or AV block alone does not lead to a high incidence of SCD. Hunt and Ross 21 reported a 3% incidence of SCD in 97 dogs that were subjected to LAD ligation. Vos et al 9, 11 reported a low incidence of spontaneous SCD (1 of 7) in dogs with AV block. These findings suggest that MI and AV block created a substrate for SCD. However, because of the absence of the spontaneous triggers, these dogs had a low incidence of SCD. Functional studies by other investigators showed that increased sympathetic tone may provoke ventricular arrhythmia both in the animal models and in human patients. 6, 13, 14, 22, 23 In our study, dogs in the experimental group had significantly more frequent VT episodes than dogs in the control group. When VT occurs with either type I or type II onset, the fast rates of these VT episodes may induce spatiotemporal heterogeneity of action potential duration and refractoriness, resulting in VT to VF transition. 2, 24 We conclude that a combination of the spontaneous ventricular arrhythmia (trigger) and the underlying anatomic and electrophysiological abnormalities (substrate) account for a high incidence of spontaneous VT, VF, and SCD in this animal model.
Nerve Sprouting and SCD Syndrome in Humans
It is known that MI results in cardiac nerve injury. 23, 25 Because peripheral nerve injury is often followed by nerve sprouting, 26 it is possible that nerve sprouting occurs after MI. Compatible with that hypothesis, Nori et al 27 demonstrated in a rat model that necrotic myocardial injury resulted in denervation followed by sympathetic regeneration. Also compatible with that hypothesis, abnormal patterns of neurilemma proliferation have been documented in infarcted human hearts 28 and that sympathetic scintigraphy demonstrated both denervation and reinnervation after MI. 23 Others reported that the nerve fibers in human hearts were usually TH-positive. 29 To demonstrate a relationship between ventricular arrhythmia and nerve sprouting in humans, we recently completed a study 30 using the pathological specimens collected from 53 native hearts of cardiac transplant recipients. We also reviewed the history to determine whether or not there were ventricular arrhythmias. Results showed that the density of nerve fibers in patients with arrhythmia was significantly higher than that in patients without arrhythmia (19.6Ϯ11.2/ mm 2 versus 13.5Ϯ6.1/mm 2 , PϽ0.05). The nerve density in patients with arrhythmia overlaps with the nerve density in the experimental group of the present study (Table) . For example, dogs 1, 2, 7, and 8 in the experimental group have sympathetic nerve densities within 1 SD from the mean nerve density in human patients with ventricular arrhythmia. These results suggest that cardiac nerve sprouting may occur after MI even without exogenous NGF. Infusion of NGF accelerated and intensified the development of nerve sprouting, resulting in a high incidence of SCD. Depending on the quantity and timing of nerve sprouting, ventricular arrhythmia and SCD may occur at different times after the MI. This sequence of events is similar to that observed in injury-related epilepsy, which is associated with abnormal nerve sprouting in the central nervous system after brain injury. 31 
Clinical Implications
The results of our study may explain the efficacy of ␤-blockers in the prevention of SCD. 32, 33 It may also explain the finding that sotalol, a drug with ␤-blocking effects, is an effective antiarrhythmic agent in patients with chronic MI. 34 In contrast, d-sotalol, a drug without significant ␤-blocking activity, increased mortality in patients with MI. 35 One clinical implication of this study is that future development of antiarrhythmic interventions should target not only the electrical remodeling but also the neural remodeling (sympathetic nerve sprouting and hyperinnervation) after MI.
Left stellectomy is effective in the prevention of SCD after MI both in animal models and in humans. 36 -38 The present study provides mechanistic insights into the efficacy of left stellectomy in the prevention of SCD.
Summary
The present study reports a high-yield model of spontaneous VT, VF, and SCD in dogs with AV block and chronic MI. The physiological and pathological evidence supports a causal relationship between enhanced sympathetic nerve sprouting and occurrence of SCD. This model may also be useful in future investigations of the mechanisms of SCD and in testing novel methods for prediction and prevention of SCD syndrome.
